Buske C - Search Results

1

The protein tyrosine kinase inhibitor SU5614 inhibits FLT3 and induces growth arrest and apoptosis in AML-derived cell lines expressing a constitutively activated FLT3.

Spiekermann K, Dirschinger RJ, Schwab R, Bagrintseva K, Faber F, Buske C, Schnittger S, Kelly LM, Gilliland DG, Hiddemann W. Spiekermann K, et al. Among authors: buske c. Blood. 2003 Feb 15;101(4):1494-504. doi: 10.1182/blood-2002-04-1045. Epub 2002 Oct 24. Blood. 2003. PMID: 12406902 Free article.

2

Proliferation of human leukemic pre-B cells induced by human bone marrow stromal cells and murine fibroblasts.

Buske C, Hiddemann W, Wörmann B. Buske C, et al. Cell Biol Int. 1994 Nov;18(11):1049-58. doi: 10.1006/cbir.1994.1028. Cell Biol Int. 1994. PMID: 7894389

3

Paraneoplastic hypokalemia in acute myeloid leukemia: a case of renin activity in AML blast cells.

Wulf GG, Jahns-Streubel G, Strutz F, Basenau D, Hüfner M, Buske C, Wörmann B, Hiddemann W. Wulf GG, et al. Among authors: buske c. Ann Hematol. 1996 Sep;73(3):139-41. doi: 10.1007/s002770050215. Ann Hematol. 1996. PMID: 8841102

4

TGF-beta inhibits growth and induces apoptosis in leukemic B cell precursors.

Buske C, Becker D, Feuring-Buske M, Hannig H, Wulf G, Schäfer C, Hiddemann W, Wörmann B. Buske C, et al. Leukemia. 1997 Mar;11(3):386-92. doi: 10.1038/sj.leu.2400586. Leukemia. 1997. PMID: 9067578

5

Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand.

Buske C, Gogowski G, Schreiber K, Rave-Fränk M, Hiddemann W, Wörmann B. Buske C, et al. Exp Hematol. 1997 Apr;25(4):329-37. Exp Hematol. 1997. PMID: 9131008

6

Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer.

Wulf GG, Jürgens B, Liersch T, Gatzemeier W, Rauschecker H, Buske C, Hüfner M, Hiddemann W, Wörmann B. Wulf GG, et al. Among authors: buske c. J Cancer Res Clin Oncol. 1997;123(9):514-21. doi: 10.1007/BF01192207. J Cancer Res Clin Oncol. 1997. PMID: 9341902

7

In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand.

Buske C, Twiling A, Gogowski G, Schreiber K, Feuring-Buske M, Wulf GG, Hiddemann W, Wörmann B. Buske C, et al. Leukemia. 1997 Nov;11(11):1862-7. doi: 10.1038/sj.leu.2400822. Leukemia. 1997. PMID: 9369419

8

TGF-beta and its receptor complex in leukemic B-cell precursors.

Buske C, Becker D, Feuring-Buske M, Hannig H, Griesinger F, Hiddemann W, Wörmann B. Buske C, et al. Exp Hematol. 1998 Nov;26(12):1155-61. Exp Hematol. 1998. PMID: 9808055

9

Clonal chromosomal abnormalities in the stem cell compartment of patients with acute myeloid leukemia in morphological complete remission.

Feuring-Buske M, Haase D, Buske C, Hiddemann W, Wörmann B. Feuring-Buske M, et al. Among authors: buske c. Leukemia. 1999 Mar;13(3):386-92. doi: 10.1038/sj.leu.2401300. Leukemia. 1999. PMID: 10086729

10

[Monoclonal antibodies in therapy of malignant lymphomas].

Buske C, Engert A, Schnell R, Diehl V, Hiddemann W. Buske C, et al. Internist (Berl). 1998 Dec;39(12):1205-14. doi: 10.1007/s001080050292. Internist (Berl). 1998. PMID: 10198827 Review. German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters